Hanna-Riikka Kreivi, MD, PhD

Department of Respiratory Medicine, Heart and Lung Center, Helsinki University Hospital, Finland, Finland

Disclosure(s): Pfizer: Advisor/Consultant; Roche: Advisor/Consultant

Poster(s):

• 1126 - Effect of Remdesivir on Recovery, Quality of Life, and Long-COVID Symptoms One Year after Hospitalization for COVID-19 Infection: A Randomized Controlled SOLIDARITY Finland Trial
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET